[Yoo Seung Rok, 1 Year in Office] New Insulin Pump Launched, Focusing on Market Expansion
[Yoo Seung Rok, 1 Year in Office] New Insulin Pump Launched, Focusing on Market Expansion
  • Cho Eun, Reporter
  • 승인 2023.10.10 22:28
  • 수정 2023.10.10 22:28
  • 댓글 0
이 기사를 공유합니다

'MiniMed 780G System'..."Diabetic patients have the biggest difficulty in meal management"
[Photo courtesy of Medtronic Korea]
[Photo courtesy of Medtronic Korea]

Medtronic Korea announced on October 10th that it has launched the MiniMed 780G System equipped with insulin infusion algorithm in Korea.

It is an automated insulin infusion pump that automatically adjusts basal as well as corrected insulin levels based on the sensor glucose value measured by a connected continuous glucose monitor.

The MiniMed 780G system automatically adjusts insulin bolus doses up to 288 times a day, every 5 minutes, based on the new SmartGuard automatic mode feature.

The SmartGuard automatic mode feature sets a certain period of time to maintain blood glucose within a target range based on a patient’s personal target blood glucose level, which is set through discussion with a healthcare provider for each patient’s individual condition.

The automatic mode target can be selected from 100, 110, and 120 mg/dL in consultation with a healthcare provider to suit individual conditions. The connected continuous glucose monitor is the Guardian 4 transmitter.

"While interest in continuous glucose monitors has increased, patients with pancreatic insufficiency diabetes, who secrete little insulin, need not only to identify and predict hypoglycemia and hyperglycemia, but also to manage blood glucose within the target range by taking insulin accordingly," said Dr Kim Jae Hyeon, professor of endocrinology at Samsung Medical Center.

Mr. Yoo Seung Rok, managing director of Medtronic Korea, said, "For insulin-dependent diabetic patients, meal management is the biggest challenge, and precise carbohydrate calculation is the most burdensome part of diabetes management. It is very encouraging to finally introduce our insulin injection algorithm to diabetic patients in Korea.“

Mr. Yoo was appointed as managing director in December last year.

He said at the time of his appointment, "I will do everything in my power to listen to the voices of our employees and domestic healthcare professionals, who have been working together, and to lead change and growth in line with the diversifying healthcare industry environment." 

Medtronic Korea was founded in 2000 and currently employs approximately 550 people.

[WIKI KOREA=Cho Eun, Reporter]

choeun@wikileaks-kr.org


  • 서울특별시 마포구 마포대로 127, 1001호 (공덕동, 풍림빌딩)
  • 대표전화 : 02-702-2677
  • 팩스 : 02-702-1677
  • 청소년보호책임자 : 소정원
  • 법인명 : 위키리크스한국 주식회사
  • 제호 : 위키리크스한국
  • 등록번호 : 서울 아 04701
  • 등록일 : 2013-07-18
  • 발행일 : 2013-07-18
  • 발행인 : 박정규
  • 편집인 : 박찬흥
  • 위키리크스한국은 자체 기사윤리 심의 전문위원제를 운영합니다.
  • 기사윤리 심의 : 박지훈 변호사
  • 위키리크스한국 모든 콘텐츠(영상,기사, 사진)는 저작권법의 보호를 받은바, 무단 전재와 복사, 배포 등을 금합니다.
  • Copyright © 2024 위키리크스한국. All rights reserved.
  • [위키리크스한국 보도원칙] 본 매체는 독자와 취재원 등 뉴스 이용자의 권리 보장을 위해 반론이나 정정보도, 추후보도를 요청할 수 있는 창구를 열어두고 있음을 알립니다.
    고충처리 : 02-702-2677 | 메일 : laputa813@wikileaks-kr.org
ND소프트